Charts Spyre Therapeutics, Inc. Deutsche Boerse AG
Stocks
3920
US00773J2024
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
07:09:06 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 74.00 EUR | 0.00% |
|
-6.33% | +170.07% |
| 09-04 | Spyre Therapeutics Insider Sold Shares Worth $2,480,529, According to a Recent SEC Filing | MT |
| 09-04 | Spyre Therapeutics Insider Sold Shares Worth $1,309,410, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Deutsche Boerse AGEUR
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SYRE | Delayed | |
CBOE
| SYRE | Real-time | |
|
Tradegate
| 3920 | Real-time | |
|
Deutsche Boerse AG
| 3920 | Delayed | |
|
Börse Stuttgart
| 3920 | Delayed |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SYRE Stock
- 3920 Stock
- Charts Spyre Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
